A joint program between EPFL Innovation Park and Groupe Mutuel
Join our next Roadshow India Oct. 10th

We accelerate women's health innovations

A global FemTech community and a 9-month equity free FemTech start-up acceleration program for companies developing innovative solutions to improve technologies relating to women’s health with international reach.
Save the date Tech4Eva Conference on November 30th
Don't miss this event to connect with the ecosystem, get insights about the industry and research trends in Femtech and discuss the growing market opportunity!
Info here
2023 Cohort BrochureNext Upcoming EventLearn More
Founding Partners
About us

Innovation platform for FemTech

9 Month Start-up Acceleration Program

The program aims to help selected start-up companies to:
  • refine their business models
  • go-to-market process strategy
  • meet investors
  • meet potential customers
  • get personalized technical and business coaching
  • gain visibility through international roadshows
Learn More

Public Events

Regularly we organize public events to:
  • raise awareness of FemTech
  • discuss topics in women's health
  • discover new solutions and technologies
  • help you expand your network
  • be inspired to create innovative solutions
Learn More

9 Month Start-up Acceleration Program

The program aims to help selected start-up companies to:
  • refine their business models
  • go-to-market process strategy
  • meet investors
  • meet potential customers
  • get personalized technical and business coaching
  • gain visibility through international roadshows
Learn More

Public Events

Multiple times per month we organize public free to attend events that help companies to:
  • expand network
  • ...
  • ...
  • ...
  • ...
Learn More
icon of an arrowSee upcoming events
View the 2023 Start-up Brochure
The Global South Initiative - call for partnerships

Discover Our Mentors

Jennifer Cubino
COO, Customer Success & Data Sciences, BC Platforms
Nicolas Loeillot
Business Models and Innovation Development - Strategy and Corporate services, CSS Insurance
Antoine Bachmann
Start-up Coach, Investor & Advisor
Frederik Decouttere
Chairman, Alithea Genomics, and AVP & SLIMS GM,Agilent
Emi Gonzalez
Senior Principal, Joyance Partners & Ataraxia VC
Xavier Mundet
Digital InnovationLAB Manager, Roche
Discover All Mentors

Discover Our Partners

BioAlps
CSEM
DayOne
Embassy of Switzerland in the United Kingdom
Essity
FemTech Analytics
Femtech France
Fermata
INSEAD Healthcare Club
Joyance Partners
RH Capital - A Rhia Ventures Fund
Roche
SICTIC
Swiss Biotech Association
Swissnex
Women of Wearables

Apply for the Acceleration Program

Calendar Icon

April 2024

Next program start date
Application Form Icon

Applications closed

Next call soon
Hourglass Icon

9 Months

Duration
2023 Cohort BrochureFrequently asked questions

News

Breaking Taboos and Advancing Women's Health in Tel Aviv's Thriving Femtech Ecosystem
September 13, 2023

Breaking Taboos and Advancing Women's Health in Tel Aviv's Thriving Femtech Ecosystem

Revolutionizing Convenience with Pads on a Roll
September 6, 2023

Revolutionizing Convenience with Pads on a Roll

Neuraura: Solving PCOS with Bioelectronic Medicine
August 23, 2023

Neuraura: Solving PCOS with Bioelectronic Medicine

Discover All Articles

Common Questions

What is FemTech?
Offering innovative solution in one or more of these areas:
  • Pregnancy & post-partum
  • Wellness
  • Period health
  • Fertility & infertility
  • Menopause
  • Mental health
  • Family life
  • Prevention
  • Treatment & Care
  • Bone, Brain Health, Immune & Heart Diseases
  • Oncology
What solutions or services are we looking for?
  • Application Software
  • Apps B2C Information platforms
  • Therapeutics/Wearable devices
  • IoT Preventive medicine
  • Diagnostics
  • Monitoring equipment
  • AI services
  • Consumer non-durables
  • Personal products
  • Outcome management and InsurTech
What stage can we apply?
The program Tech4Eva is open to start-ups and innovative projects from Switzerland, Europe and around the globe. We will accept both early and late stage companies. Ideally you are working on your go-to-market strategy and/or are considering fundraising.
Is there a fee to apply or participate in the program?
There is no fee to apply nor to participate in the program as the program is fully sponsored. We do not take any equity. Selection will be done by merit.
When is the next cohort?
The 4th FemTech program Tech4Eva will run from April - November 2024. The next call for application is launched December, 2023.
What is the application deadline?
Please ideally apply before February 1st to give the selection committee time to review all applicants before the opening ceremony 2024 (date TBC).
Does the Founder or CEO need to be a woman?
We do not require that the Founder nor CEO of your start-up is a woman. We accept all Founders or CEOs building products and solutions for women’s health.
Does our company need to be based in Switzerland during the program?
Although our program is based in Switzerland, we expect the program to be a hybrid format and adapted to the latest COVID-19 restrictions. We will aim to have key events in presence if possible such as the kickoff and closing.
What are the benefits to take part in the program?
  • Access to one of Europe’s leading healthcare ecosystems
  • 9 months of tailored coaching and specialized workshops
  • Develop pilot projects with Group Mutuel or its partner companies
  • Access to potential customers through international collaborations
  • Exposure to international investors
  • Access to a unique knowledge from payer’s perspective
  • A desk at La Forge, the incubator of EPFL Innovation Park in Lausanne.
  • Direct feedback from a panel of technology experts from EPFL network and the University

Contact Us

For question linked to partnership, sponsorship, mentorship and investment: please contact Lan Zuo Gillet: zuo@epfl-innovationpark.ch
For other details about the program, please contact Simone Theiss: theiss@epfl-innovationpark.ch
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.